Ballentine Partners »

Iradimed shares owned by Ballentine Partners

Quarter-by-quarter ownership of Iradimed (IRMD) shares owned by Ballentine Partners from 13F filings

Historical chart of Ballentine Partners investment in Iradimed

Tip: Access up to 7 years of quarterly data

All positions including Iradimed held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iradimed by Ballentine Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $211k 2.2k 97.28

More positions owned by Ballentine Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Glb Infrastr Etf (IGF)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Ballentine Partners

Top funds holding Iradimed

BlackRock
Vanguard Group
Renaissance Technologies
Nine Ten Capital Management
Copeland Capital Management
Geode Capital Management
T. Rowe Price Investment Management
Dimensional Fund Advisors
Goldman Sachs Group
State Street Corporation
Acadian Asset Management
Northern Trust
Ranger Investment Management
Russell Investments
Millennium Management

View all funds holding Iradimed